AEON Biopharma, Inc. (AEON) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $3.01M | +23023.1% |
| 2024 | $13.0K | -99.7% |
| 2023 | $5.16M | -47.1% |
| 2022 | $9.75M | +1859.3% |
| 2021 | $497.4K | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $3.01M | +23023.1% |
| 2024 | $13.0K | -99.7% |
| 2023 | $5.16M | -47.1% |
| 2022 | $9.75M | +1859.3% |
| 2021 | $497.4K | — |